Physician profile
Raul Cortes
NPI 1932273240
$4,211.19
in general payments reported to CMS, 2019-2025
14 companies · $2,073 in 2025
The $2,073 reported for 2025 was more than what 83% of Surgery of The Hand (Surgery) providers received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $581 · 2021: $5.06 · 2022: $704 · 2023: $304 · 2024: $414 · 2025: $2,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,539 · Travel and Lodging: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,539.32 |
| Travel and Lodging | $251.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,289.63 | 2022-2025 | |
| Sonex Health, INC. | $892.09 | 2021-2025 | Sx-One Microknife |
| Arthrex, INC. | $557.21 | 2020 | |
| Integra Lifesciences Corporation | $408.86 | 2019-2023 | Durasorb Monofilament Mesh |
| Abbvie INC. | $244.57 | 2024-2025 | |
| Sientra, INC. | $221.45 | 2022 | |
| Axogen | $216.37 | 2022-2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Motiva USA, LLC | $159.84 | 2025 | |
| Polynovo North America LLC | $78.26 | 2024 | Novosorb Btm |
| Bioventus LLC | $38.66 | 2019-2025 | Xcell |
| Djo, LLC | $35.82 | 2025 | Cmf |
| Acumed LLC | $34.28 | 2023 | Acumed, Inframe Implant, Innate Implant |
| Incyte Corporation | $18.21 | 2024 | Jakafi |
| Kerecis Limited | $15.94 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raul Cortes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.